Home
Our News
About Us
Contact Us
Partners
Cash Giveaway
Advertise Here
Search
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
RAPTOR PHARM
(NQ:
RPTP
)
7.790
USD
UNCHANGED
Official Closing Price
/ Updated:
4:00 PM EDT, Jun 19, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
7.790
Bid (Size)
7.790 (1400)
Ask (Size)
7.800 (10500)
Prev. Close
7.790
Today's Range
7.710 - 8.090
52wk Range
4.350 - 7.990
Shares Outstanding
56,754,823
Dividend Yield
N/A
Top News
More News
Raptor's PROCYSBI(TM) Now Commercially Available in the U.S. for Nephropathic Cystinosis Patients
June 19, 2013
Prescription Claims Have Been Approved by Payors and Are Now Being Filled at Accredo Specialty Pharmacy
Read More
from
GlobeNewswire News Releases
Raptor Pharmaceutical to Present at Upcoming Investor Conference
June 12, 2013
from
GlobeNewswire News Releases
More News
Read More
GSK, AZN, KERX, and RPTP Early Briefing and Review
June 07, 2013
from
ACCESSWIRE
Record Use of At-the-Market (ATM) Offerings Continues in 2013 with $161 Million Raised by U.S. Life Sciences Companies in First Quarter, Reports Brinson Patrick
May 28, 2013
from
PR Newswire
Free Research Reports on CAMT, DSCO, JRCC and RPTP Issued by the Paragon Report
May 21, 2013
from
Marketwired News Releases
Bio-Wire Equity Surveillance – Closing Bell 5/20/2013
May 20, 2013
category
RPTP
,
ACAD
,
MDXG
, and 15 more.
from
Bio-Wire.Com
Raptor Pharmaceutical Reports First Quarter Calendar Year 2013 Financial Results
May 08, 2013
from
GlobeNewswire News Releases
Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome
May 07, 2013
category
Contracts
,
Management
,
Benzinga
, and 4 more.
from
Latest Articles from Benzinga.com
Raptor Pharmaceutical Licenses Intellectual Property for Rett Syndrome From French Research Institutes
May 07, 2013
from
GlobeNewswire News Releases
Bio-Wire Weekly: April 29 – May 3rd, 2013
May 06, 2013
category
Prime Content
,
AEGR
,
REGN
, and 5 more.
from
Bio-Wire.Com
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
© Copyright 2003 - eZanga.com, Inc.All Rights Reserved.
